# Phase II Study of Neo-adjuvant Chemoradiotherapy for Squamous Cell Esophageal Cancer

> **NCT02938195** · PHASE2 · UNKNOWN · sponsor: **Shanghai Chest Hospital** · enrollment: 50 (estimated)

## Conditions studied

- Esophageal Cancer
- Chemoradiation
- Surgery

## Interventions

- **RADIATION:** radiotherapy
- **PROCEDURE:** Surgery

## Key facts

- **NCT ID:** NCT02938195
- **Lead sponsor:** Shanghai Chest Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-01
- **Primary completion:** 2018-01
- **Final completion:** 2018-01
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2016-10-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02938195

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02938195, "Phase II Study of Neo-adjuvant Chemoradiotherapy for Squamous Cell Esophageal Cancer". Retrieved via AI Analytics 2026-07-28 from https://api.ai-analytics.org/clinical/NCT02938195. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*